Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India · Delayed Price · Currency is INR 506.00
+2.65 (0.53%)
At close: Dec 5, 2025
Dr. Agarwal's Health Care Revenue
Dr. Agarwal's Health Care had revenue of 4.99B INR in the quarter ending September 30, 2025, with 19.71% growth. This brings the company's revenue in the last twelve months to 18.77B, up 25.00% year-over-year. In the fiscal year ending March 31, 2025, Dr. Agarwal's Health Care had annual revenue of 17.11B with 28.44% growth.
Revenue (ttm)
18.77B
Revenue Growth
+25.00%
P/S Ratio
8.52
Revenue / Employee
n/a
Employees
4,214
Market Cap
159.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.11B | 3.79B | 28.44% |
| Mar 31, 2024 | 13.32B | 3.14B | 30.86% |
| Mar 31, 2023 | 10.18B | 3.22B | 46.25% |
| Mar 31, 2022 | 6.96B | 2.25B | 47.73% |
| Mar 31, 2021 | 4.71B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |